IntrinsicIntrinsic
← Scroll for more →

Financial Statements — PFSA

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents0.720.381.783.010.000.020.020.000.010.010.000.020.010.060.190.370.480.510.74
Total Current Assets0.840.663.764.200.690.060.260.680.110.071.580.150.240.350.510.710.830.911.10
Property, Plant & Equipment0.080.010.01--------------------------------
Total Non-current Assets*0.200.200.010.061.271.922.818.108.488.439.3110.6510.6610.39194.22193.09192.03191.96191.96
Total Assets1.040.863.784.251.961.983.078.788.598.5010.8810.8010.9010.74194.74193.79192.86192.87193.06
Accounts Payable7.868.317.356.98----4.95------------------------
Short-term Debt--------------------0.20----------------
Total Current Liabilities28.1729.0222.2623.5416.1813.2557.135.174.163.964.923.002.972.650.940.400.160.090.11
Long-term Debt----------------------0.710.37------------
Total Non-current Liabilities*0.000.048.1814.676.961.040.000.650.960.660.170.670.421.430.890.972.043.347.22
Total Liabilities28.1729.0630.4338.2123.1414.3057.135.825.114.635.093.673.394.091.831.372.203.427.32
Retained Earnings(172.99)(164.24)(160.78)(152.21)(22.51)(14.30)(124.96)(5.18)(5.08)(4.50)(3.46)(3.48)(2.87)(3.31)(0.62)(0.37)(1.12)(2.20)(5.91)
Total Stockholder Equity(27.13)(28.20)(26.66)(33.96)(22.51)(14.30)(119.20)(5.18)(5.08)(4.50)(3.46)(3.48)(2.87)(3.31)(0.62)(0.37)(1.12)(2.20)(5.91)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Total Revenue------0.08----------------------------
Research & Development0.821.151.250.72----------------------------
Selling, General & Admin1.722.862.3220.99----------------------------
Total Operating Expenses2.554.013.5721.710.030.01------------------------
Operating Income(2.54)(4.01)(4.45)(21.71)(0.97)(0.58)(0.31)(0.32)(0.25)(0.47)(0.46)(0.29)(0.31)(0.44)(0.41)(0.40)(0.22)(0.24)
Pretax Income--------(8.19)(1.10)(7.57)0.11(0.37)(0.80)0.26(0.34)0.870.820.911.811.24--
Tax Provision--------0.000.020.020.020.020.020.030.030.020.380.430.040.03--
Net Income(8.76)(3.46)(4.31)(22.19)(8.20)(1.12)(7.59)0.09(0.40)(0.82)0.24(0.37)0.850.440.481.761.213.71
Basic EPS(151.80)(2.05)(10,459.00)(70.00)(153.00)(19.00)(128.00)2.00(7.00)(14.00)2.00(6.00)14.002.003.007.005.0015.00
Diluted EPS(151.80)(2.05)(10,459.00)(70.00)(153.00)(19.00)(128.00)2.00(7.00)(14.00)(18.00)14.0014.002.002.007.005.00--
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(2.63)(2.58)(5.13)(10.62)(0.14)(0.36)(0.33)(0.29)(0.39)(0.28)(0.35)(0.48)(0.27)(0.97)(0.18)(0.11)(0.06)(0.23)
Capital Expenditures0.070.01--------------------------------
Free Cash Flow*(2.70)(2.58)--------------------------------
Investing Cash Flow(0.07)1.15(1.01)(7.49)-0.006.490.46(0.11)0.072.56(0.08)0.15(0.15)185.67-0.000.000.03--
Financing Cash Flow3.050.034.9120.940.12(6.13)(0.11)0.400.33(2.28)0.410.340.37(184.85)--------
← Scroll for more columns →

* Derived from reported values